The Journal of Pediatrics
Volume 143, Issue 1 , Pages 9-10 , July 2003

Precocious puberty: McCune-Albright syndrome and beyond

  • Paul Saenger, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Paul Saenger, MD, Division of Pediatric Endocrinology, Children's Hospital at Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 2100th St, The Bronx, NY 10467-2490.
    • ,
  • Marielisa Rincon, MD

References 

  1. Rosenfield RL. Normal and almost normal variants of precocious puberty: premature pubarche and premature thelarche revisited. Horm Res. 1994;41:7
  2. Lee PA. Central precocious puberty. An overview of diagnosis, treatment, and outcome. Endocrinol Metab Clin North Am. 1999;28:901–918
  3. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, et al.  Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Setting network. Pediatrics. 1997;99:505–512
  4. Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implication for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins pediatric Endocrine Society. Pediatrics. 1999;104:936–941
  5. Rosenfield RL, Bachrach LK, Chemausek SD, Gertner JM, Gottschalk M, Hardin DS, et al.  Current age of onset of puberty. Pediatrics. 2000;106:622–623
  6. New York Times. Doubters fault theory finding earlier puberty. February 20, 2001; A1, A16.
  7. Midyett LK, Moore WV, Jacobson JD. Are pubertal changes in girls before age 8 benign?. Pediatrics. 2003;111:47–51
  8. Eugster E, Rubin S, Reiter E, Plourde P, Jou H, Pescovitz O. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr. 2003;143:61–67
  9. Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the α subunit of the stimulatory G protein of adenyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A. 1992;89:5152
  10. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Eng J Med. 1991;325:1688
  11. Styne DM. The testes. In:  Sperling MA editors. Disorders of sexual differentiation and puberty in the male. Pediatric endocrinology. Philadelphia: Saunders; 2002;p. 611
  12. Lala R, Matarazzo P, Bertelloni S, Buzzi F, Rigon F, de Sanctis C. Pamidronate treatment of fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr. 2000;89:88–92
  13. Kappy MS, Stuart TE, Perelman AH, Clemons RD. Supression of gonadotropin secretion by a long-acting gonadotropin–releasing hormone analog (leuprolide acetate, Lupron Depo) in children with precocious puberty. J Clin Endocrinol Metab. 1989;87:1087–1089
  14. Carel J, Lahlou N, Jaramillo O, Montauban V, Tenturier C, Colle M, et al.  Treatment of central precocious puberty by subcutaneous injection of Leuprorelin 3-month Depo (11.25 mg). J Clin Endocrinol Metab. 2002;87:4111–4116
  15. Bhatia S, Neely K, Wilson D. Serum luteinizing hormone rises within minutes after Depo Leuprolide injection: implications for monitoring therapy. Pediatrics. 2002;109:1–6
  16. Bar A, Linder B, Sobel EH, Saenger P, DiMartino-Nardi J. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr. 1995;126:955–958

PII: S0022-3476(03)00272-5

doi: 10.1016/S0022-3476(03)00272-5

The Journal of Pediatrics
Volume 143, Issue 1 , Pages 9-10 , July 2003

Article Tools